Enhancement of TLR-Mediated Innate Immune Responses by Peptidoglycans through NOD Signaling

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|32|4163-4172

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.32, 2006-11, pp. : 4163-4172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two Key Challenges for Effective Adenovirus-Mediated Liver Gene Therapy:Innate Immune Responses and Hepatocyte-Specific Transduction

By  

Current Gene Therapy, Vol. 9, Iss. 2, 2009-04 ,pp. : 115-127

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Innate Immune Responses in the Treatment of Sepsis and Pneumonia

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 1, 2004-03 ,pp. : 11-17

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Innate Immune Responses in the Central Nervous System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 4-24

Bentham Science Publishers

Access to resources Recommend Favorite

Host Innate Immune Responses Induced by Baculovirus in Mammals

By  

Current Gene Therapy, Vol. 10, Iss. 3, 2010-06 ,pp. : 226-231

Bentham Science Publishers

Access to resources Recommend Favorite

Role of DAP12 in Innate and Adaptive Immune Responses

By  

Current Pharmaceutical Design, Vol. 9, Iss. 1, 2003-01 ,pp. : 7-10

Bentham Science Publishers

Access to resources Recommend Favorite